Vaccinogen Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$3.73 M |
Shares Outstanding |
37.32 M |
Public Float |
- |
Address |
949 Fell Street Baltimore Maryland 21231 United States |
Employees | - |
Website | http://www.vaccinogeninc.com |
Updated | 09/14/2018 |
Vaccinogen, Inc. is an immunotherapy company. The company engages in the development and commercialization of vaccines and immunotherapeutic products for cancer. Its primary product, OncoVAX is a vaccine for post-surgical treatment of stage II colon cancer. |